Clinical Trial Update: MOVE Protocol - Movement-Oriented Velocity of Engagement [NA]

View source ↗

Summary

This update notes that the MOVE Protocol trial examining movement-oriented velocity of engagement for acute and subacute musculoskeletal pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Snippet

Sponsor: MMSx Authority Institute for Movement Mechanics and Biomechanics Research Inc | Conditions: Musculoskeletal Pain - Acute and Subacute Conditions | NA | Status: COMPLETED